Stem cells are derived from the
human cells. Stem cell therapy is also known as regenerative medicine. The
therapy has the ability to regenerate human cells, tissues, or organs, in order
to restore normal functioning of the body. Stem cell therapies are used in the
treatment of spinal cord injury, Parkinson’s disease, sickle cell disease,
diabetes, and heart diseases.
Statistics:
The global stem
cells market is estimated to account for US$ 9,941.2 Mn in terms of value
in 2020 and is expected to reach US$ 18,289.9 Mn by the end of 2027.
Global Stem Cells Market: Drivers
Increasing adoption of stem cells
for the treatment of various diseases is expected to propel growth of the
global stem cells market over the forecast period. For instance, in June 2019,
Personalized Stem Cells, Inc. submitted an Investigational New Drug Application
(IND) to the U.S. FDA for utilizing patients own adipose-derived stem cells to
treat their osteoarthritis.
Global Stem Cells Market:
Opportunities
R&D in stem cells is expected
to offer lucrative growth opportunities for players in the global stem cells
market. For instance, in January 2020, researchers at Biomedical Research
Institute, MEDIPOST Co., Ltd., South Korea, reported analysis of the effects of
spheroid umbilical cord blood-derived mesenchymal stem cells (MSCs) and
suggested a new therapeutic approach, 3D spheroid formation of MSCs, in order
to enhance the regeneration process in the course of osteoarthritis.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/4222
Global Stem Cells Market:
Restraints
Government regulations against
unethical harvesting of stem cells are expected to hinder growth of the global
stem cells market. For instance, in the U.S., the ban on federal funding had
been imposed since 1974, and was lifted as late as 2009. Ban has also been
enforced in certain European nations such as Germany, Austria, Portugal and
Italy and some Asian nations such as China, South Korea and Israel.
Key Takeaways:
The global stem cells market was
valued at US$ 9,112.0 Mn in 2019 and is forecast to reach a value of US$
18,289.9 Mn by 2027 at a CAGR of 9.1% between 2020 and 2027. Major factor
driving the growth of global stem cells market during the forecast period
include increasing research and development, and increasing applications of
regenerative medicine.
Adult stem cells held dominant
position in the global stem cells market in 2019, accounting for 81.2% share in
terms of value, followed by Human Embryonic Stem Cells and Induced Pluripotent
Stem Cells, respectively. Increasing use of adult stem cells in regenerative
medicine is supporting growth of the segment.
Market Trends
Adoption of stem cells in R&D
is expected to propel growth of the global stem cells market. For instance, in
December 2019, in the journal Cell Reports, researchers from the University of
California Los Angeles reported development of accurate model of organ scarring
using stem cells in a lab.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/stem-cells-market-4222
Moreover, approval and launch of
novel CAR-T therapies is also expected to aid in growth of the market. For
instance, in November 2018, Novartis AG received an approval from the European
Commission for its CAR-T (Kymriah) for treatment of B-cell acute lymphoblastic
leukemia in pediatric and adult patients.
Global Stem Cells Market:
Competitive Landscape
Major players operating in the
global stem cells market include, Advanced Cell Technology, Inc., Angel
Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics.,
BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene
Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori
Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc.
Global Stem Cells Market: Key
Developments
Major players in the market are
focused on adopting collaboration and partnership strategies to expand their
product portfolio. For instance, in September 2020, Lineage Cell Therapeutics,
Inc., ES Cell International Pte Ltd., a subsidiary of Lineage, and AgeX
Therapeutics, Inc., a company focused on developing and commercializing
innovative therapeutics for human aging, announced the broadening of their
collaborative relationship with regard to ES Cell International Pte Ltd. stem
cell lines.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/4222
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment